Novo Nordisk and AWS Launch Strategic AI Partnership to Accelerate Drug Discovery

Novo Nordisk and Amazon Web Services (AWS) announced a strategic partnership on 10 August 2026 to accelerate drug discovery and modernise Novo Nordisk’s operations through agentic AI and cloud technologies. The agreement establishes AWS as Novo Nordisk’s preferred cloud provider and strategic AI partner.

As part of the partnership, the companies have created a co-innovation hub in London where engineers and scientists from both companies are using AWS AI technologies alongside Novo Nordisk data and insights to compress the path from drug target to first human dose. The hub brings together AWS engineers, AI specialists, and applied scientists with Novo Nordisk research and development teams to increase productivity and help reduce the time to market for future medicines.

"Partnering with AWS is about making AI a driver of innovation across Novo Nordisk," said the president and CEO of Novo Nordisk. "By combining our scientific expertise with AWS’s tools and purpose-built services for the life sciences industry, while also creating a dedicated co-innovation hub within our existing facility in London, we are accelerating discovery and developing responsible AI solutions that will create real progress for people living with serious chronic diseases."

Novo Nordisk has already seen measurable results from the collaboration, including reducing clinical documentation time and empowering more than 25,000 employees to boost productivity. The new agreement builds on a longstanding relationship and will create the secure foundations needed to turn ideas into new therapies for patients around the world. This includes using services such as Amazon Bio Discovery and Amazon Bedrock to identify drug targets, design new therapies faster, and connect genomic, imaging and clinical data so that breakthroughs in early research can shape clinical trial design. Novo Nordisk will also leverage Amazon Bedrock AgentCore to drive efficiencies across its operations through AI agents.

Novo Nordisk collaborates with multiple Amazon businesses that support the healthcare industry, including Amazon Pharmacy, Amazon Ads, and Amazon One Medical, to transform how new therapies are marketed and delivered to patients.

Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark. The company employs about 66,700 people in 80 countries and markets its products in around 170 countries.